Multiple batch manufacturing of theophylline pellets using the wet-extrusion/spheronization process with κ-carrageenan as pelletisation aid

References

• Ghebre-Sellassie I. (1989). Pharmaceutical pelletization technology. New York: Marcel Dekker.
   Google Scholar
• Knop K. (1991). Pellets. In Hagers Handbuch der Pharmazeutischen Praxis. Berlin: Springer Verlag.
   Google Scholar
• Ghebre-Sellassie I, Martin C. (2003). Pharmaceutical Extrusion Technology. New York, Basel: Marcel Dekker.
   Google Scholar
• Baert L, Vermeersch H, Remon JP, Smeyers-Verbeke Massart DJ. Study of parameters important in the spheronisation process. International Journal of Pharmaceutics 1993;96:225–229.
   Web of Science ®Google Scholar
• Newton JM, Chapman SR, Rowe RC. The influence of process variables on the preparation and properties of spherical granules by the process of extrusion and spheronisation. Int J Pharm 1995;120:101–109.
   Web of Science ®Google Scholar
• Dawes CJ. Seasonal and reproductive aspects of plant chemistry, and ι-carrageenan from Floridian Eucheuma (Rhodophyta, Gigartinales). Bot Mar 1977;20:137–148.
   Web of Science ®Google Scholar
• Voragen ACJ. (2002). Carrageenan. In Ullmann’s encyclopedia of industrial chemistry. Weinheim: Wiley-VCH.
   Google Scholar
• Bornhöft M, Thommes M, Kleinebudde P. Preliminary assessment of carrageenan as excipient for extrusion/spheronisation. Eur J Pharm Biopharm 2005;59:127–131.
   PubMed Web of Science ®Google Scholar
• Yoo A, Kleinebudde P. Spheronization of small extrudates containing κ-carrageenan. J Pharm Sci 2009;98:3776–3787.
   PubMed Web of Science ®Google Scholar
• Stoltenberg I, Winzenburg G, Breitkreutz J. Solid oral dosage forms for children – Formulations, excipients and acceptance issues. J Appl Ther Res 2011;7:141–146.
   Google Scholar
• O’Connor RE, Schwartz JB. Spheronization II: Drug release from drug-diluent mixtures. Drug Dev Ind Pharm 1985;11:1837–1857.
   Web of Science ®Google Scholar
• Kleinebudde P. The crystallite-gel-model for microcrystalline cellulose in wet-granulation, extrusion, and spheronization. Pharm Res 1997;14:804–809.
   PubMed Web of Science ®Google Scholar
• Bechgaard H, Nielsen GH. Controlled-release multiple-units and single-unit doses – a literature review. Drug Dev Ind Pharm 1978;4:53–67.
   Web of Science ®Google Scholar
• Thommes M, Kleinebudde P. Use of κ-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type. Eur J Pharm Biopharm 2006;63:68–75.
   PubMed Web of Science ®Google Scholar
• Yoo A. (2009). K-Carrageenan micropellets – production and dissolution behavior. Goettingen: Cuvillier.
   Google Scholar
• Fix I. (2004). Anwendung der quantitativen Röntgendiffraktometrie (QXRD) in der pharmazeutischen Analytik. PhD thesis. Bonn: University Bonn.
   Google Scholar
• Matsuo K, Matsuoka M. Kinetics of humidity driven solid-state polymorphic transition of theophylline anhydrates. J Chem Eng Jpn 2007;40:541–549.
   Web of Science ®Google Scholar
• Suzuki E, Shimomura K, Sekiguchi K. Thermochemical study of theophylline and its hydrate. Chem Pharmaceut Bull 1989;37:493–497.
   Web of Science ®Google Scholar
• Kleinebudde P. Use of a power-consumption-controlled extruder in the development of pellet formulations. J Pharm Sci 1995;84:1259–1264.
   PubMed Web of Science ®Google Scholar
• Steckel H, Mindermann-Nogly F. Production of chitosan pellets by extrusion/spheronization. Eur J Pharm Biopharm 2004;57:107–114.
   PubMed Web of Science ®Google Scholar
• Thommes M, Blaschek W, Kleinebudde P. Effect of drying on extruded pellets based on κ-carrageenan. Eur J Pharm Sci 2007;31:112–118.
   PubMed Web of Science ®Google Scholar
• Lindner H, Kleinebudde P. Characterization of pellets by means of autonomic image analysis. Pharmind 1993;55:694–701.
   Google Scholar
• Bouwman AM, Visser MR, Eissens AC, Wesselingh JA, Frijlink HW. The effect of vessel material on granules produced in a high-shear mixer. Eur J Pharm Sci 2004;23:169–179.
   PubMed Web of Science ®Google Scholar
• Shipway PH, Hutchings IM. Fracture of brittle spheres under compression and impact loading. I. Elastic stress distributions. Phil Mag A 1993;67:1389–1404.
   Google Scholar
• von Hattingberg HM, Brockmeier D, Voegele D. Analysis of statistical moments and in vitro/in vivo correlation. Acta Pharmaceutica Technologica 1984;30:93–101.
   Google Scholar
• Charoenthai N, Kleinebudde P, Puttipipatkhachorn S. Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization. J Pharm Sci 2007;96:2469–2484.
   PubMed Web of Science ®Google Scholar
• Liew CV, Gu L, Soh JL, Heng PW. Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: A promising alternative to microcrystalline cellulose. Pharm Res 2005;22:1387–1398.
   PubMed Web of Science ®Google Scholar
• Sousa JJ, Sousa A, Podczeck F, Newton JM. Factors influencing the physical characteristics of pellets obtained by extrusion-spheronization. Int J Pharm 2002;232:91–106.
   PubMed Web of Science ®Google Scholar
• Umprayn K, Chitropas P, Amarekajorn S. Influence of process variables on physical properties of the pellets using extruder and spheronizer. Drug Dev Ind Pharm 1999;25:45–61.
   PubMed Web of Science ®Google Scholar
• Kleinebudde P, Schröder M, Schultz P, Müller BW, Waaler T, Nymo L. Importance of the fraction of microcrystalline cellulose and spheronization speed on the properties of extruded pellets made from binary mixtures. Pharm Dev Technol 1999;4:397–404.
   PubMed Web of Science ®Google Scholar
• Ticehurst MD, Storey RA, Watt C. Application of slurry bridging experiments at controlled water activities to predict the solid-state conversion between anhydrous and hydrated forms using theophylline as a model drug. Int J Pharm 2002;247:1–10.
   PubMed Web of Science ®Google Scholar
• Seton L, Khamar D, Bradshaw IJ, Hutcheon GA. Solid state forms of theophylline: Presenting a new anhydrous polymorph. Cryst Growth Des 2010;10:3879–3886.
   Web of Science ®Google Scholar
• Kleinebudde P. Shrinking and swelling properties of pellets containing microcrystalline cellulose and low substituted hydroxypropylcellulose: I. Shrinking properties. Int J Pharm 1994;109:209–219.
   Web of Science ®Google Scholar
• Thommes M, Kleinebudde P. Use of κ-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler. Eur J Pharm Biopharm 2006;63:59–67.
   PubMed Web of Science ®Google Scholar